Nasdaq:US$16.36 (-0.09) | HKEX:HK$26.10 (-0.45) | AIM:£2.71 (+0.01)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF